Active surveillance for early-stage prostate cancer: review of the current literature. - Wikidata - awgldk - TriplyDB

Active surveillance for early-stage prostate cancer: review of the current literature.

Active surveillance for early-stage prostate cancer: review of the current literature.

http://www.wikidata.org/entity/Q37096700

about

New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis Outcomes of localized prostate cancer following conservative management Management of low (favourable)-risk prostate cancer Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance.The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer.Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth Challenges in clinical prostate cancer: role of imaging.Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database Should active surveillance in prostate cancer patients be based on a single histological assessment?Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer.Patient perspective on watchful waiting/active surveillance for localized prostate cancer.A multi-institutional evaluation of active surveillance for low risk prostate cancer.Improving prostate cancer detection in veterans through the development of a clinical decision rule for prostate biopsy.Outcomes of active surveillance for men with intermediate-risk prostate cancer.Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma.BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.Refusal of radiation therapy and its associated impact on survival.PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.Changes in circulating microRNA levels associated with prostate cancer.Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance Our results of active surveillance for localized prostate cancer patients.Risk stratification of men choosing surveillance for low risk prostate cancer.Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions Prostate cancer brachytherapy: guidelines overview.Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer.Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.Active surveillance for prostate cancer compared with immediate treatment: an economic analysis Detection rate of clinically insignificant prostate cancer increases with repeat prostate biopsies Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells.

P2860

Q21143810-5E0644C1-9540-418E-ACDD-310E033DF0D4 Q24645292-8045914F-6B49-4C4B-B700-7713B8CDD4AB Q24647380-62C812CF-6141-4D99-8B0D-6919E0AAB8B1 Q26996501-A83A5EAB-FB61-4E0F-93DC-06875541FEAA Q31133702-EF5F0146-5C0E-4D97-AE05-63D9714A9CE0 Q33617669-43850ED1-065C-439E-8E5D-F676F2FD7739 Q33658285-A4171742-3810-464D-9E90-5CB1B10A1B74 Q33925625-36FBF497-4665-4CC4-8458-421E37F1A208 Q33945133-197EAD80-FF29-4272-B2CE-8EB38162A717 Q33964345-1148B382-790F-4E01-AF6B-65121EE8C673 Q33965083-8256C18E-D479-46DA-AB19-BEE0073380E7 Q34017813-0A452839-65E5-4518-A0A2-3811B3CC748F Q34127059-1576C933-5377-45BB-93F3-D77F8CFF0A42 Q34195092-E9DABB78-9EBA-434C-92C3-979C08AF1EC5 Q34364108-0ACFC9C7-B7F6-48F2-8B4C-0D75B0F8A908 Q34407351-B25C2EEE-F509-4B0D-B937-48FB2813BBDA Q34419421-67892F77-2D66-408F-9A32-9EA6237B2067 Q34541484-12EB0A53-3EF5-4243-8A82-385EC996172D Q34565363-B2D4E7FE-7A84-4C3E-9CDD-FF152626029E Q34679207-61FB8D4F-191A-46A8-A9B4-2FABA419EC1A Q34760295-D9F4F5BC-D12B-4030-A8F6-E95D8FB488CD Q34773720-F1577434-94F7-47CA-B983-A586DDF97BFE Q34989460-1B8D0ABB-D77C-41B7-9369-C0583F3C80FD Q35110766-B7EDE41E-08E2-4118-86EC-861270E85D0E Q35112386-BFAC3439-E8C5-4765-92D8-7B7126670990 Q35700730-CC19B360-72B3-44C0-9A16-A63F7BEF2764 Q35879858-2F536B44-7CF9-4E6F-98C4-DEE7857DC16C Q35991695-2E87B7D3-A592-4A40-AB89-84E42F2E98F6 Q35993855-142F5242-F06A-44DE-8261-22382F8EA333 Q36328870-86E55564-4AA7-4970-8160-68A191DFDEA0 Q36378954-7E89D167-72D4-4918-A68A-E6DF32FA388C Q36520523-B5A966DD-0136-4AC0-AEA6-9DA0FCE798B4 Q36555616-DE75CCE8-BED4-4B29-A81C-45642CDBB335 Q36653022-E0D02803-801E-47C2-8F17-CF961BEA4FD4 Q36757440-33D38917-AFE7-41E0-BF5E-A933CF8AC0FB Q36905270-7F0C162B-2740-4319-8B96-A60DE9DD19C2 Q36973544-9B1CC483-B1C0-4453-A471-52DA287BF158 Q37084223-7F2BE8DA-68A1-4440-A936-CD11BAE522D1 Q37307609-100DE004-E0FF-4616-B0EA-D30F5E89ED2B Q37436655-C4016EFD-83BB-46F9-BE6E-82207A3079A8

P2860

Active surveillance for early-stage prostate cancer: review of the current literature.

http://www.wikidata.org/entity/Q37096700

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Active surveillance for early-stage prostate cancer: review of the current literature.

@en

Active surveillance for early-stage prostate cancer: review of the current literature.

@nl

type

label

Active surveillance for early-stage prostate cancer: review of the current literature.

@en

Active surveillance for early-stage prostate cancer: review of the current literature.

@nl

prefLabel

Active surveillance for early-stage prostate cancer: review of the current literature.

@en

Active surveillance for early-stage prostate cancer: review of the current literature.

@nl

P1433

Q37096700-444A851A-B121-4570-B1D9-016B096FAA26

P1476

Q37096700-92138DE1-F78F-4C07-9B7F-9C363E3F937F

P2093

Q37096700-131F766C-68CF-434F-B6A4-1A593FF98955

Q37096700-1D963121-2589-47FE-B4BD-2082F6D726CD

Q37096700-393B0D31-B1C0-4111-949F-B3570A689509

Q37096700-955E3B7E-045F-4AA7-A0AF-FC143EE30D71

Q37096700-BFC1EB5B-B49D-414D-B488-188EED132400

Q37096700-E2252111-38B6-4026-88CB-5FA05FD51A76

Q37096700-F535A7C3-AAC2-4C44-BEF0-4677BFB979CF

Q37096700-F79F2ABD-A9FA-4961-8C45-102852EF90D4

Q37096700-FAAD01AC-97CD-4429-B426-A753CDDB7284

P2860

Q37096700-152A176F-421B-4339-949F-5A6B77076E39

Q37096700-CBC5084B-BAD6-40AD-95D9-FA0B188D632F

P304

Q37096700-0C935CD4-7A9B-4B82-A4F7-C6D36F295BB4

P31

Q37096700-4BFBDC5A-E255-4394-A83D-2961C57333BA

P356

Q37096700-14CECCF8-BCFF-4E41-AE82-F99806B6C3A8

P407

Q37096700-0138E16F-762E-46C6-A42C-02E1344F16F5

P433

Q37096700-E623C19A-46AE-405B-9509-3B9470D346F9

P478

Q37096700-2AD2E213-8667-494A-A80D-7D326B639046

P50

Q37096700-249FAF7A-3562-4660-9861-A6C33DDC3C22

Q37096700-4593DE19-05CB-4E96-B755-BD60B0FFECCE

Q37096700-72F5A52F-44B4-4FCB-B46F-4CE24858F131

P577

Q37096700-2971FAD2-E21B-44FD-9008-CB49FD3C87C1

P5875

Q37096700-A9ED3FFF-1A86-4D20-95EE-06FFAA670CF9

P698

Q37096700-AE0DB14C-26BD-4D76-9BBB-924CF713850F

P356

P1433

P1476

Active surveillance for early-stage prostate cancer: review of the current literature.

@en

P2093

Benjamin J Davies

http://www.w3.org/2001/XMLSchema#string

Christopher A Warlick

http://www.w3.org/2001/XMLSchema#string

Donald E Bailey

http://www.w3.org/2001/XMLSchema#string

June M Chan

http://www.w3.org/2001/XMLSchema#string

Laurence H Klotz

http://www.w3.org/2001/XMLSchema#string

Marc A Dall'Era

http://www.w3.org/2001/XMLSchema#string

Meredith E Wallace

http://www.w3.org/2001/XMLSchema#string

Peter C Albertsen

http://www.w3.org/2001/XMLSchema#string

Peter R Carroll

http://www.w3.org/2001/XMLSchema#string

P2860

Expectant treatment with curative intent in the prostate-specific antigen era: triggers for definitive therapy.

Active surveillance with selective delayed intervention for favorable risk prostate cancer.

P304

1650-1659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.23373

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Philip W. Kantoff

Matthew R Cooperberg

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5546842

http://www.w3.org/2001/XMLSchema#string

P698

18306379

http://www.w3.org/2001/XMLSchema#string